NCT01073631View on ClinicalTrials.gov

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

CompletedOBSERVATIONAL
Enrollment

543

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Serious Fungal Infections
Interventions
DRUG

voriconazole tablet

200 mg PO bid (orally, twice a day)

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY